Years of Experience: 25+ years
London, United Kingdom
University College London (UCL) Cancer Institute, UK
Prof. Gerhardt Attard is a Clinician-Scientist and Director of the University College
London Cancer Institute, specializing in prostate cancer therapeutics and biomarkerdiscovery. He has pioneered the clinical and translational research underpinningabiraterone acetate, transforming treatment paradigms for metastatic prostatecancer.
His laboratory at UCL integrates molecular biology, bioinformatics, and clinicaloncology to study resistance mechanisms and develop liquid biopsy strategies forprecision medicine.
Prof. Attard’s work has shaped international prostate cancer managementguidelines and established new standards for molecular stratification in clinicaltrials, making him a global leader in translational oncology and prostate cancergenomics